AlphaYouAC
Insider selling
Andrew Callos sold $702K of Cytokinetics Inc (CYTK) stock
Andrew Callos, EVP, Chief Commercial Officer of Cytokinetics Inc (CYTK), sold 10,000 shares of CYTK stock worth $702K, per an SEC Form 4 filed Aug 31, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Aug 31, 2026.
CYTK has moved -4.7% since the trade date, from $70.91 to $67.56 (Sep 21, 2026 close).
- Traded
- Aug 31, 2026
- Disclosed
- Aug 31, 2026
- Filing delay
- 0 days
- Price since
- -4.7%
- Role
- EVP, Chief Commercial Officer
- Source
- SEC Form 4
More CYTK insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.